RHABDOID TUMOR OF THE KIDNEY
Clinical trials for RHABDOID TUMOR OF THE KIDNEY explained in plain language.
Never miss a new study
Get alerted when new RHABDOID TUMOR OF THE KIDNEY trials appear
Sign up with your email to follow new studies for RHABDOID TUMOR OF THE KIDNEY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for tough kidney cancer
Disease control OngoingThis study tests whether adding the targeted therapy cabozantinib to standard immunotherapy (nivolumab and ipilimumab) helps people with advanced kidney cancer live longer. About 1,175 adults with kidney cancer that has spread will receive either the usual treatment or the usual …
Matched conditions: RHABDOID TUMOR OF THE KIDNEY
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC
-
Immunotherapy combo shows promise for rare childhood tumors
Disease control OngoingThis phase 2 trial is testing two immunotherapy drugs, nivolumab and ipilimumab, in children and young adults with rare INI1-negative cancers that have come back or not responded to treatment. The study aims to see if the combination can shrink tumors or slow disease progression.…
Matched conditions: RHABDOID TUMOR OF THE KIDNEY
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC